HSPH1 and colorectal carcinoma: Notably, prior studies by Duval’s team suggested that the large deletion of HSP110 T17 correlated with ACT efficacy, either with fluorouracil alone or combined with oxaliplatin, in CRC patients with dMMR.33 Regrettably, this effect was not consistently observed in subsequent studies.34,35